Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
76,851,274
-
Total 13F shares
-
5,476,932
-
Share change
-
+669,636
-
Total reported value
-
$45,239,000
-
Price per share
-
$8.26
-
Number of holders
-
25
-
Value change
-
+$5,117,394
-
Number of buys
-
11
-
Number of sells
-
15
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q3 2015
As of 30 Sep 2015,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,476,932 shares.
The largest 10 holders included
BVF INC/IL, Capital World Investors, FMR LLC, ROYAL BANK OF CANADA, Invesco Private Capital, Inc., Visium Asset Management, LP, Point72 Asset Management, L.P., PERCEPTIVE ADVISORS LLC, Opaleye Management Inc., and Novo A/S.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.